- FRTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Fresh Tracks Therapeutics (FRTX) 8-K7 Mar 23FRTX-02 was generally safe and well tolerated within the potential therapeutic dose range, meeting the study’s primary objectivesFinancial data
Company Profile